Nancy Hutson

(Dr. Nancy Hutson Ph.D.)

Currently holds positions in Clearside Biomedical Inc and BioCryst Pharmaceuticals Inc

Positions
Position Company Period
Director Clearside Biomedical Inc April 21, 2020 -
Independent Director BioCryst Pharmaceuticals Inc Jan. 20, 2012 -
Independent Director Cubist Pharmaceuticals LLC June 12, 2008 - Jan. 21, 2015
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-10-04 2023-10-03
B Purchase
10,000 +12.0%
0.86
8,600 USD 		10,000 +12.0% 0.86 8,600 USD
2023-06-15 2023-06-14
S Sale
12,866 -13.6%
8.04
103,443 USD 		12,866 -13.6% 8.04 103,443 USD
2022-11-21 2022-11-17
B Purchase
30,000 +56.6%
1.33
39,900 USD 		30,000 +56.6% 1.33 39,900 USD
2021-10-19 2021-10-15
PS Planned sale
105,000 -61.7%
15.40
1,617,000 USD 		105,000 -61.7% 15.40 1,617,000 USD
2021-08-17 2021-08-16
B Purchase
3,000 +30.0%
5.68
17,040 USD 		3,000 +30.0% 5.68 17,040 USD
2021-06-14 2021-06-10
PS Planned sale
23,333 -26.4%
16.86
393,394 USD 		23,333 -26.4% 16.86 393,394 USD
2021-03-15 2021-03-12
B Purchase
5,000 +100.0%
3.11
15,525 USD 		5,000 +100.0% 3.11 15,525 USD
2020-05-21 2020-05-20
B Purchase
5,000 +inf%
1.85
9,250 USD 		5,000 +inf% 1.85 9,250 USD
2018-12-17 2018-12-17
B Purchase
1,000 +inf%
4.46
4,460 USD 		1,000 +inf% 4.46 4,460 USD